Clearpoint Neuro Inc expected to post a loss of 13 cents a share - Earnings Preview

Clearpoint Neuro

07/08/2021 03:03

* Clearpoint Neuro Inc  CLPT.OQ   CLPT.O  is expected to show a
rise in quarterly revenue when it reports results on August 10. 
* The Solana Beach, California-based company is expected to
report   a 48.7% increase in revenue to $3.685 million from
$2.48 million a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Clearpoint Neuro Inc is
for a loss of 13 cents per share. For the same quarter last
year, the company reported a loss of 11 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Clearpoint
Neuro Inc is $35​, about 36.4% above​ its last closing price
of $22.25. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Mar. 31 2021  -0.14       -0.14      -0.13     Beat    10.3
 Dec. 31 2020  -0.13       -0.13      -0.09     Beat    30.8
 Sep. 30 2020  -0.14       -0.14      -0.09     Beat    35.7​
 Jun. 30 2020  -0.16       -0.16      -0.11     Beat    31.3
 Mar.          -0.18​      -0.18      -0.13     Beat    27.8​
 31​ 2020​                                              
                                                        ​
 This summary was machine generated August 7 at 02:03 GMT.  All
figures in US dollars unless otherwise stated